Protection from chemical injury is dependent on sequence variation in NS1/2. We previously showed that compared with the CW3 
T he microbiome includes intestinal bacteria that contribute to the development of the immune system, defend against opportunistic infections, and impact the development of autoimmune and inflammatory diseases. Bacteriophages, animal viruses and endogenous viral elements that represent the virome are also numerous, diverse and prevalent in humans and model organisms 1 . Alterations in the composition of the enteric virome have been observed in various pathological conditions, suggesting that the presence or absence of certain viruses in the gastrointestinal tract contribute to disease development 2 . Although many animal viruses have been detected in intestinal specimens, insight into the mechanisms by which enteric viruses influence host physiology beyond their roles as pathogens is lacking. An understanding of the viral and host factors involved in establishing mutually beneficial relationships could influence the design and implementation of microbiome-based therapies, which currently focus on exploiting bacterial communities.
Studies with murine norovirus (MNV) provide direct evidence that viruses can function similarly to the bacterial members of the microbiome. MNV is a single-stranded RNA virus that frequently establishes a persistent asymptomatic gastrointestinal infection in mice. Like commensal bacteria, MNV induces or exacerbates intestinal inflammation in genetically susceptible backgrounds [3] [4] [5] . In mice with a mutation in the autophagy gene Atg16L1, a model of the inflammatory bowel disease Crohn's disease, we showed that MNV infection triggers structural defects in small intestinal Paneth cells similar to patients harbouring the disease-associated variant of ATG16L1 3, 6 . MNV-infected Atg16L1-mutant mice also display increased mortality following chemical injury to the intestine by dextran sodium sulphate (DSS) 3, 7 . Conversely, we demonstrated in wild-type (WT) antibiotic (ABX)-treated and germ-free (GF) mice that the same MNV strain restores intestinal morphology and lymphocyte differentiation, which are defective due to the absence of bacteria 8 . In addition, and in stark contrast to Atg16L1-mutant mice, MNV protects ABX-treated mice from DSS-induced mortality 8 . Subsequently, other groups showed that MNV enhances colonization resistance against vancomycin-resistant Enterococcus after ABX treatment and reduces lung injury following infection with Pseudomonas aeruginosa 9, 10 . This property of MNV, where infection can be beneficial in certain situations yet induces disease in a susceptible background, is reminiscent of the complex symbiotic relationship between the host and the bacterial microbiota.
Endogenous viruses and synthetic viral RNA were shown to protect against DSS through the production of type I interferon (IFN-I) by dendritic cells 11, 12 . Similarly, we demonstrated that MNVmediated protection against DSS in ABX-treated mice is dependent on the IFN-I receptor (IFNAR1), implicating this conserved antiviral pathway in the protective effects of viral infection 8 . Ifnar1
−/− mice that were not treated with ABX, and thus harboured an intact bacterial microbiota, were similar to WT mice and resistant to DSS under the same conditions. These findings raise the possibility that virus-mediated protection occurs through a mechanism that is distinct from the way an intact bacterial microbiota fortifies the barrier, which we examine here.
strain, the CR6 strain of MNV confers greater protection from DSS to ABX-treated mice 8 . Although MNV CR6 and CW3 share ~95% amino acid sequence identity, they display significant differences in their virulence. The VP1 major capsid protein of MNV CW3 accounts for the ability of this strain to cause lethality when introduced into immunocompromised Stat1 −/− mice [13] [14] [15] . The lessvirulent CR6 strain evades recognition by lymphocytes to establish persistent infection 16 , which is attributed to sequence variation in NS1/2 17 . We used recombinant complementary DNA clones of MNV, in which the VP1 and NS1/2 regions were swapped between CR6 and CW3 (Fig. 1a) , to determine which of these factors contribute to protection from DSS.
We first used GF mice to verify our previous observations made in ABX-treated mice. Unlike mice infected with CW3, GF mice infected with CR6 displayed similar survival levels to conventional mice following the administration of DSS, indicating that the CR6 strain has the ability to compensate for the complete absence of bacteria ( Fig. 1b and Supplementary Fig. 1a ). Although no chimaeric virus was able to induce the same level of protection as CR6, we observed significant differences. Sequence variation in VP1 did not contribute to protection as the CR6 mutant harbouring VP1 from CW3 (CR6.VP1 CW3 ), but not the converse (CW3.VP1 CR6 ), improved the survival of GF mice (Fig. 1c) . In contrast, the CW3 mutant harbouring NS1/2 from CR6 (CW3.NS1/2 CR6 ) gained the ability to promote survival, whereas the CR6 mutant harbouring NS1/2 from CW3 (CR6.NS1/2 CW3 ) lost this ability (Fig. 1d) . We previously demonstrated that protection against DSS correlates with the ability of MNV to restore the width of small intestinal villi in bacterially depleted mice 8 . We found that the strains that enhanced survival during DSS treatment (MNV CR6, CR6.VP1 CW3 and CW3.NS1/2 CR6 ) increased the villus width of GF mice (Fig. 1e,f) . Therefore, NS1/2 contributes to the differential response to MNV CR6 and CW3 infection.
We detected all virus strains in the stool at day 10 post infection, which is indicative of productive infection, albeit at lower levels than conventional mice, consistent with the role of bacteria in promoting MNV infection 8, 18, 19 . However, the parental CR6 strain replicated to higher titres (Fig. 1g) . We did not detect any correlation between extra-intestinal spread and survival following DSS treatment ( Supplementary Fig. 1b) . A more efficient intestinal infection could explain why GF mice infected with CR6 display the highest degree of survival, even when compared with CW3.NS1/2 CR6 infection. Importantly, CW3.NS1/2 CR6 (which protects against DSS) and the original CW3 strain (which does not provide protection) display similar degrees of shedding, indicating that additional factors are important for determining the effect of MNV infection on intestinal injury. NS1/2 contributes to IFN-I signalling and proliferation of colonic epithelial cells. NS1/2 sequence variation is associated with persistence in the colon of conventional mice 17, 20 . We hypothesized that chimaeric viruses have differences in the ability to replicate in the colon during injury and drive local viral RNA sensing, which is important for the protective IFN-I response. Consistent with this possibility, we observed a correlation between the amount of MNV RNA from the chimaeric viruses and expression of the representative IFN-stimulated genes (ISGs) OasL2, Mx2 and Isg15 in the colonic tissue of virally infected GF mice treated with DSS (Fig.  2a) . Although previously shown to primarily infect leukocytes, recent findings indicate that MNV also infects intestinal epithelial cells (IECs), especially tuft cells 20, 21 . Only CR6 and CW3.NS1/2 CR6 genomes were detectable in sorted IECs and lamina propria leukocytes (LPLs), indicating that CW3 and CR6.NS1/2 CW3 are unable to persist in the colon following DSS treatment (Fig. 2b) . The presence of viral RNA in IECs rather than LPLs was a better indicator of ISG expression and IFN-I expression (Ifnb1) was detectable in LPLs but not IECs (Fig. 2c and Supplementary Fig. 1c) . These results suggest that, although the epithelial tropism of MNV is important for persistence in the local niche, immune cells are probably the main producers of IFN-β and IECs are the responding cells under these conditions.
Mice deficient in Irgm1, a negative regulator of IFNAR1 signalling, display enhanced wound healing due to increased IEC proliferation 22 . Similarly, we found that GF mice infected with MNV CR6 and CW3.NS1/2 CR6 , but not those infected with MNV CW3 or CR6.NS1/2
CW3
, showed increased staining of the proliferation marker Ki67 in the colon (Fig. 2d) . The IFN-I response to MNV is dependent on the recognition of viral RNA by cytosolic sensors that signal through the adaptor molecule MAVS [23] [24] [25] . Unlike Mavs +/+ controls, MNV CR6 infection of ABX-treated Mavs −/− mice did not induce ISGs, protect against DSS or restore the width of the small intestinal villi, despite productive viral replication ( Supplementary  Fig. 2a-d) . MNV CR6 infection of bone marrow-derived dendritic cells (BMDCs) induced MAVS-dependent expression of Ifnb1 and Mx2 (Supplementary Fig. 2e) intestinal organoids, a three-dimensional cell culture in which epithelial lineages are differentiated from primary progenitor cells ( Supplementary Fig. 2f ). These data support a role for MAVSinduced IFN-I production by leukocytes in response to MNV persistence in the colon, which is associated with protective epithelial proliferation.
Protection from DSS by MNV is dependent on IL-22. We and others have shown that MNV infection increases the numbers of IL-22-producing group 3 innate lymphoid cells (ILC3s) and IFN-γ + T cells in GF or ABX-treated mice 8, 9 . MNV CR6 retained the ability to improve the survival of ABX-and DSS-treated IFN-γ receptor (Ifngr −/− ) mice but was unable to protect similarly treated Il22 −/− mice ( Fig. 3a-c) . Il22 −/− mice that received DSS without ABX displayed 100% survival, indicating that IL-22 is dispensable at this particular dose and duration of DSS treatment when intestinal bacteria are intact, and that this cytokine is especially necessary to overcome the heightened sensitivity to injury when bacteria are depleted. The loss of protection in Il22 −/− mice could not be explained by lower levels of intestinal virus (Fig. 3e) . Increased villus width was observed following CR6 infection in ABX-treated WT, and to a lesser extent Ifngr −/− mice, but not IL-22 −/− mice (Fig. 3d ). These observations support the idea that the widening of villi reflects an increase in leukocytes and IEC proliferation downstream of an immune response to local viral replication.
We next examined whether MNV induces phosphorylation of STAT3 (pSTAT3) in the colon, as activation of this transcription factor downstream of IL-22 signalling mediates wound repair following DSS treatment 26 . We detected an IL-22-dependent increase in pSTAT3
+ cells in the colon following infection with MNV CR6, whereas the positive control pSTAT1 (induced by IFN-I, IFN-λ and IFN-γ) was detectable in all conditions (Fig. 3f-h ). Interestingly, we found that MNV was also unable to induce pSTAT3 staining in the colon of Ifnar1 −/− mice (Fig. 3h) . MNV CR6 infection still induced significant ISG expression in Il22 −/− mice ( Supplementary Fig. 3a ), indicating that IFN signalling is not dependent on IL-22. MNV CR6 infection increased the proportion and absolute numbers of IL-22-producing ILCs in the colonic lamina propria in ABX-and DSStreated WT but not Ifnar1 −/− mice ( Fig. 3i-j and Supplementary  Fig. 3b ,c and e). Viral infection increased the IFN-γ + CD4 + T cell populations (but not IL-22
+ or IL-13 + CD4 + T cells) in an IFNAR1-dependent manner (Fig. 3i,j and Supplementary Fig. 3d,f) ; however, our earlier results (Fig. 3b) show that IFN-γ was not involved in protection from injury. MNV CR6 evoked similar responses in GF mice following DSS administration ( Supplementary Fig. 3g,h ). IL-22 secretion in colonic explants and pSTAT3 staining in colonic , n = 18 mice. The survival curves were analysed using the log-rank Mantel-Cox test. Villus width and log 10 -transformed stool titres were analysed using an analysis of variance (ANOVA) with Dunnett's multiple comparisons test to compare to GF mice and CR6-infected GF mice, respectively. All bars represent the mean and the error bars represent the s.e.m. All P values are shown; ns, not significant. tissue sections were also increased in GF mice infected with MNV CR6 (Supplementary Fig. 3i,j) . Together, these results indicate that MNV CR6 increases colonic IL-22 following intestinal damage.
Activation of ILC3s following bacterial infection of the colon is dependent on the recruitment of CCR2 + monocytes 27 . We found that MNV CR6 infection did not increase the proportion of IL-22 + ILCs in the colon of ABX-treated Ccr2 −/− mice, indicating that similar mechanisms are necessary for virus-mediated activation of ILC3s (Fig. 4a) . Despite viral burdens that were equivalent or higher compared with WT mice, MNV CR6 induced minimal protection from DSS injury in ABX-treated Ccr2 −/− mice (Fig. 4b,c) . We observed an increase in several CCR2-dependent MHCII + myeloid populations in the colon following infection with MNV CR6 ( Supplementary  Fig. 4a and Fig. 4d ). Among these infiltrating cells, MNV-induced increases in CD11b low CD11c +
CD103
− cells were observed in GF and ABX-treated WT mice but not ABX-treated Ifnar1 −/− mice ( Fig. 4e and Supplementary Fig. 4b ). Other MHCII + populations were not dependent on IFN-I signalling and recruitment of all subsets following infection remained intact in Il22 −/− mice (Fig. 4e) . Therefore, MNV-mediated protection from injury is associated 
WT Conv (n = 8) mice at day 6 post DSS administration. WT ABX, n = 15 and 6; WT ABX + CR6, n = 15 and 6; Ifnar1 −/− ABX, n = 12 and 9; and Ifnar1 −/− ABX + CR6, n = 14 and 10 mice for i and j, respectively. The survival curves were analysed using the log-rank Mantel-Cox test. An ANOVA with Dunnett's multiple comparisons test was used to analyse the villus width and log 10 -transformed MNV titres compared with ABX and WT mice, respectively. A two-tailed Student's t-test was used to analyse the STAT expression levels. An ANOVA with Tukey's multiple comparisons test was used to analyse the flow cytometry data. All bars represent the mean and the error bars represent the s.e.m. All P values are shown.
with IFN-dependent alterations to myeloid populations upstream of IL-22 expression by ILC3s.
IFN-I signalling in IECs is required for protection.
Although deletion of Ifnar1 in IECs alters the composition of the bacterial microbiota 28 , other studies have shown that IECs are unresponsive to IFN-I and implicate a dominant role for IFN-λ signalling in inhibiting enteric RNA viruses 19, [29] [30] [31] . In contrast to Ifnar1 f/f control mice, MNV infection of ABX-treated Ifnar1 f/f ; Villin-Cre mice in which Ifnar1 is deleted in IECs (Ifnar1 ΔIEC ) did not enhance survival following DSS injury or restore villi width (Fig. 5a-c) . We did not observe an IEC-specific role for IFNAR1 in restricting MNV burden (Fig. 5d) . The ability of MNV CR6 to induce pSTAT3 staining was eliminated in Ifnar1
ΔIEC , but not, Ifnar1 f/f mice (Fig. 5e ). Recombinant IFN-β induced Mx2 expression in human and mouse intestinal organoids (Fig. 6a-c) , confirming that IECs can directly respond to IFN-I. According to our model, STAT3 is activated by IL-22 directly and IFN-I indirectly during MNV infection. We found that IL-22, but not IFN-β, induced pSTAT3 and REG3β in organoids (Fig. 6d,e and Supplementary Fig. 6 ). These findings show that IECs respond to IFN-I and that STAT3 phosphorylation is an independent event. MNV-induced increases in IL-22 (Fig. 6f-g and Supplementary Fig. 4c,d) . We then performed RNA sequencing analysis on sorted IECs from Ifnar1 f/f and Ifnar1 ΔIEC mice following DSS administration, with or without viral infection. MNV CR6 infection led to an increased expression of genes representing cell-cycle regulation and DNA damage response pathways in a manner dependent on epithelial IFNAR1 (Fig. 6h) . This IFNAR-dependent gene expression pattern is consistent with MNV-induced IEC proliferation (Fig. 2d) and is remarkably similar to a recently described IL-22-induced transcriptional response that prevents genotoxic damage to epithelial stem cells in the colon 32 . Together, these data indicate that IFNAR signalling in the epithelium mediates the beneficial effect of MNV infection and decouples the role of IFN-I in antiviral versus injury responses.
MNV protects against enteric bacterial infection during development.
Over time, the gastrointestinal tract becomes exposed to diverse animal viruses after birth 33 . It is unclear how the presence of these viruses affects disease caused by enteric bacterial pathogens, which are also a common occurrence during childhood. To examine the consequences of coinfection, three-week-old WT mice were challenged with the Gram-negative bacterial pathogen Citrobacter rodentium, with or without concurrent MNV CR6 infection. In the absence of the virus, WT mice failed to grow and succumbed to C. rodentium infection, whereas almost all of the MNV CR6-infected mice survived and gained weight (Fig. 7a) . MNV CR6 did not provide any benefit to three-week-old Il22 −/− mice (Fig. 7b) . Next, we took advantage of the observation that lymphocyte-deficient Rag1 −/− mice have a compensatory increase in IL-22-producing ILC3s during a similar developmental period as the above coinfection model 34 . We hypothesized that this increase in ILC3s would serve a similar purpose to MNV infection and thus Rag1 −/− mice will no longer be dependent on MNV for survival during C. rodentium infection. Rag1 −/− mice were indeed protected from bacterial infection irrespective of MNV infection, which was associated with an overall increase in ILCs ( Supplementary Fig. 5a,b) . Therefore, enhancing IL-22 + ILC3s through viral infection or genetically is associated with protection against secondary bacterial infection in juvenile animals.
IL-22 is more important for reducing intestinal inflammation than for reducing the burden of intestinal C. rodentium in adult mice 35 . Consistent with this observation, MNV CR6 infection of WT mice led to a modest or no reduction in bacterial burdens (Fig. 7c-e) . Furthermore, similar numbers of C. rodentium were recovered from the stools of MNV-infected WT and Il22 −/− mice. We instead observed that MNV CR6 infection reduced intestinal pathology in an IL-22-dependent manner (Supplementary Fig.  5c ). Protection from C. rodentium infection was independent of the MNV strain, as CW3-infected WT mice showed increased survival and weight gain (Supplementary Fig. 5d ). Protection from C. rodentium infection was also maintained in Ifnar1 −/− mice ( Supplementary Fig. 5e ). Thus, sequence variation in NS1/2 and IFNAR1 signalling does not contribute to protection from bacteria-induced injury.
It is possible that MNV protects young mice by accelerating the development of the microbiota because the compositional shift in intestinal bacterial communities that occurs during neonatal development is key to C. rodentium resistance 36 . However, we did not detect significant changes in the gut microbiota due to MNV infection or absence of IL-22 ( Supplementary Fig. 5f ). Instead, MNV-mediated protection from C. rodentium was associated with a general increase in the proportion of CD4 + and CD8 + T cells in the colon, which was not observed in MNV-infected Il22 −/− mice (Fig. 7f) . In addition, MNV CR6 increased the proportion of IFN-γ-expressing CD8 + T cells and ILCs in an IL-22-dependent manner and, similar to the DSS model, the presence of the virus was associated with IL-22 + ILCs (Fig. 7g,h ).
Discussion
The bacterial members of the gut microbiota acquired during development promote the maturation of the immune system and intestinal barrier. This mutualistic host-microbiota relationship can be disrupted in adulthood by ABX treatment, diet or other factors that alter bacterial community structures. Tremendous effort has thus been placed in understanding the mechanistic basis of this relationship and clinical trials are attempting to remodel the microbiota in diseased individuals by transplanting isolated microorganisms or faeces from healthy donors. Despite accumulating evidence of the presence of a dynamic enteric virome that begins to take shape after birth 33 , it is unknown how intestinal viruses impact the resilience of the intestinal barrier to damage caused by environmental agents. Using two distinct models, we show that MNV infection improves the outcome of intestinal injury through IL-22.
In the chemical injury model, we demonstrate that compensation for the absence of beneficial bacteria by MNV is associated with the NS1/2 region of the viral genome. NS1/2 from mouse and human noroviruses binds the host molecule VAMP-associated protein A (VAPA), which potentially mediates membrane remodelling during viral replication [37] [38] [39] . NS1/2 is structurally disordered and subject to cleavage, suggesting that it can adopt additional conformations with alternate functions that are currently unknown 40 . NS1/2 from the protective MNV CR6 strain confers the ability to replicate and persist in colonic IECs, leading to a local IFN-I response that is probably downstream of MAVS-dependent IFN-β production in neighbouring immune cells, although we cannot rule out an epithelial contribution of IFNβ. Our extensive analyses of Ifnar1 ΔIEC mice indicate that IECs are the IFN-responding cell type.
We further found that MNV induces IL-22-producing ILC3s in an IFNAR1-and CCR2-dependent manner. Unlike IFN-λ, which acts on neutrophils to protect against DSS 41 , we identified a role for IFN-I acting on IECs to mediate the recruitment or activation of CCR2-dependent cells during MNV infection. Recently, we showed that enhanced IFN-I signalling due to autophagy inhibition in IECs alters the function of CCR2-dependent monocytes 42 . Thus, it is also plausible that augmenting IFN-I signalling through MNV CR6 infection also induces functional changes to these populations. A role for macrophages in the activation of ILC3 has been previously demonstrated following C. rodentium infection 27 . We therefore hypothesize that alterations in the proportions and potentially the function of macrophage populations, through IFNAR1-mediated responses in IECs, affects the ability of these cells to promote IL-22 production by ILC3s.
MNV-mediated protection of young mice from C. rodentium is also IL-22-dependent. The mechanism is distinct from another study that reported that MNV confers resistance to vancomycinresistant Enterococcus in ABX-treated adult mice involving a virus-dependent reduction in bacterial colonization 9 . Vancomycinresistant Enterococcus is a Gram-positive bacterium that is sensitive to antimicrobial REG molecules produced in response to IL-22, whereas other functions, such as epithelial repair, may be more important for protecting against Gram-negative bacteria such as C. rodentium, especially in young mice. It was recently shown that MNV recruits CCR2-dependent monocytes to the mesenteric lymph node (MLN) in an IFNAR1-independent manner to support systemic persistence 43 . Although we identified a subset of myeloid cells that were IFNAR1 dependent, this was not universal across all subsets. Therefore, unlike the DSS model, accumulation of IFNAR1-independent macrophages may be sufficient to provide protection following C. rodentium infection, which would explain why IFNAR1 is dispensable and MNV CW3 is able to provide protection. Due to its increased virulence compared with other strains, infection of mice with MNV CW3 has been used as a surrogate for pandemic human norovirus GII.4 strains. Given that up to 30% of asymptomatic infants and children are positive for norovirus RNA in the stool 44 , concurrent infection with bacterial pathogens is likely to be commonplace. Our results raise the possibility that underlying norovirus infections may have a protective role when the virus is not evoking diarrhoeal disease.
The inter-strain diversity between human noroviruses is far greater than the sequence differences between MNV strains, yet little is known about how different noroviruses impact the mucosal immune system of the human gut. This lack of knowledge applies to other enteric viruses as well. Elegant work combining observations in mice and humans implicates reoviruses and noroviruses in the onset of celiac disease in a virus strain-dependent manner 45, 46 . Cytomegalovirus can reactivate in the gastrointestinal tract and contribute to inflammatory bowel disease flares but was shown to enhance epithelial turnover in mice, which presumably improves resistance to injury 22 . These observations resemble some aspects of our findings with MNV showing that an intestinal virus can be either beneficial or adverse depending on the strain and properties of the host. Finally, we wish to note that few studies investigating the effect of the bacterial microbiota exclude the possibility that results are driven by the presence of MNV or other enteric viruses, such as astroviruses, that are common in mouse facilities. We suggest that the host immune response to enteric viral infections requires attention beyond its antiviral function and needs to be considered in microbiota studies.
Methods
Mice. GF mice on a C57BL/6J background were bred and maintained in flexiblefilm isolators in the New York University (NYU) School of Medicine Gnotobiotics Animal Facility. Absence of fecal bacteria was confirmed monthly, as before −/− mice were provided by S. Koralov (NYUMC). Ifnar1 fl mice were bred to Villin-cre mice to produce cre +/− and cre −/− littermates. Mavs −/− mice on a B6129SF2/J background were bred to C57BL/6J mice to produce Mavs +/− mice that were crossed to each other to produce Mavs −/− and Mavs +/+ littermates. All other knockout strains were on the C57BL/6J background and C57BL/6J mice were used as WT controls. All mice were bred onsite in an MNV and Helicobacternegative specific-pathogen free animal facility. Randomly assigned age-(8-10 weeks) and gender-matched mice were used for the DSS experiments, in which MNV-infected mice were compared with uninfected littermates to control for potential microbiota differences between mice originating from different breeding pairs. Age-matched 12-14-day-old litters, which were generated from two pregnant 
The dams were littermates from the previous generation. All young mice were weighed daily throughout the experiment. The sample size for animal experiments was chosen based on previous data generated in the laboratory. All animal studies were performed according to protocols approved by the NYU School of Medicine Institutional Animal Care and Use Committee. ; Sigma) and 1% sucrose (Sigma) for the ABX treatments. ABX-containing water was replaced at least once a week. The mice were treated with this ABX cocktail for at least 10 d before infection. The mice were given 3% DSS (TdB Consultancy), with or without the ABX cocktail, in their drinking water for 6 d, followed by regular or ABX-containing drinking water for the remainder of the experiment. The GF mice were given 3% DSS in filtersterilized water for 5 d. The mice were monitored daily for survival.
MNV and bacterial inoculation. Plasmids for chimaeric MNV strains were previously described 17 . Two viruses were on a CR6 backbone containing the indicated gene from CW3: CR6.VP1 CW3 and CR6.NS1/2
CW3
. Two viruses were on a CW3 backbone containing the indicated gene from CR6: CW3.VP1 CR6 and CW3.NS1/2
CR6
. Chimaeric viruses, CW3 and CR6 were prepared and titrated as described previously 8 . The mice were infected orally by pipette with 3 × 10 6 plaqueforming units (p.f.u.) resuspended in PBS (Corning). C. rodentium DBS100 was grown overnight in Luria-Bertani broth with shaking at 37 °C and diluted 1:100, followed by an additional 4 h of growth until the bacteria were at an optical density of 2. The mice were gavaged with 2 × 10 7 colony-forming units (c.f.u.). Bacterial inocula were determined by serial dilution plating on MacConkey plates.
Detection of infectious MNV and C. rodentium in organs. Stools, ileum (2 cm), ascending colon (2 cm), livers, spleens and MLNs were harvested from MNVinfected mice at 10 d.p.i. The organs were weighed and homogenized in serumfree DMEM (Corning). The titres of MNV were determined by plaque assays as previously described 8 . The titres are shown as p.f.u. g −1 or p.f.u. cm Organoid culture. Murine small intestinal and colonic organoids were cultured as described previously 7 . At day 5 (small intestine) or day 3 (colon), organoids were stimulated with either 500 U ml −1 IFN-β (PBL Assay Science), 5 ng ml Colon explant culture and IL-22 detection. The colon tissue (1 cm) was opened longitudinally, washed with PBS and cultured for 48 h in 500 μl complete RPMI containing 2 mM l-glutamine (Corning), penicillin/streptomycin solution (Corning), 20 mM HEPES (Corning), MEM non-essential amino acids (Corning), 1 mM sodium pyruvate (Corning) and β-mercaptoethanol (Gibco). The IL-22 in supernatants was measured using the mouse IL-22 ELISA MAX Deluxe kit (Biolegend) according to the manufacturer's instructions.
RNA isolation and qPCR. RNA from BMDCs and colonic tissue (1 cm) homogenized using a TissueRuptor (Qiagen) was isolated using the Qiagen RNeasy mini kit with DNase treatment (Qiagen). RNA from sorted IECs and LPLs was isolated using the RNeasy micro kit with DNase treatment (Qiagen). RNA from intestinal organoids was isolated with TRIzol reagent (Fisher Scientific) as per the manufacturer's protocol and the DNA was digested using RNase-free DNase (Thermo Fisher Scientific). Synthesis of cDNA was conducted with the ProtoScript M-MuLV first strand cDNA synthesis kit (New England Biolabs). Quantitative PCR was performed using SybrGreen (Roche) on a Roche480II Lightcycler using the following primers: mHprt (accession no. J00423), Fwd 5′-GTCATGCCGACCCGCAGTC-3′ and Rev 5′-GTCCTGTCCATAATCAGTCCATGAGGAATAAAC-3′; m18S (accession no. NR_003278), Fwd 5′-TAGAGGGACAAGTGGCGTTC-3′ and Rev 5′-CGCTGAGCCAGTCAGTGT-3′; mIfnb1 (accession no. X14455), Fwd 5′-TCAGAATGAGTGGTGGTTGC-3′ and Rev 5′-GACCTTTCAAATCGAGTAGATTCA-3′; mMx2 (accession no. KX774217), Fwd 5′-CCAGTTCCTCTCAGTCCCAAGATT-3′ and Rev 5′-TACTGGATGATCAAGGGAACGTGG-3′; mOasL2 (accession no. NM_011854), Fwd 5′-GGATGCCTGGGAGAGAATCG-3′ and Rev 5′-TCGCCTGCTCTTCGAAACTG-3′; mIsg15 (accession no. NM_015783), Fwd 5′-GGTGTCCGTGACTAACTCCAT-3′ and Rev 5′-TGGAAAGGGTAAGACCGTCCT-3′; hβ-actin (accession no. NM_001101), Fwd 5′-TCACCGGAGTCCATCACGAT-3′ and Rev 5′-CCCAGCCATGTACGTTGCTA-3′; and hMx2 (accession no. NM_002463), Fwd 5′-AAACTGTTCAGAGCACGATTGAAG-3′, Rev 5′-ACCATCTGCTCCATTCTGAACTG-3′. Relative expression of the respective genes to either Hprt (murine organoids),18S (murine colon or sorted cells) or β-actin (human organoids) expression was calculated using the ΔΔC T method and the values were expressed as fold change from uninfected mice or untreated organoids. Absolute MNV genome copies were determined using a standard curve and the following primers: Fwd 5′-CAGATCACATGCTTCCCAC-3′ and Rev 5′-AGACCACAAAAGACTCATCAC-3′.
Immunoblotting. Organoids were isolated and processed for immunoblotting as previously described 7 . Briefly, protein was run through a 4-12% gradient protein gel (BioRad), transferred onto a PVDF membrane and blocked using Odyssey Blocking buffer (LI-COR). The membranes were stained with mouse anti-STAT3 and rabbit anti-pSTAT3 (Tyr705) and detected using IRDye 680RD goat anti-rabbit IgG and IRDye 800CW goat anti-mouse IgG (LI-COR) on an Odyssey CLx nearinfrared-fluorescence imaging system. RNA deep sequencing. The cDNA libraries were prepared with the Ovation Trio Low Input RNA-Seq System V2 (NuGEN) and sequenced on Illumina's HIseq platform using a paired-end protocol at the NYU Genomics Core. On average, each sample yielded 25 × 10 6 paired reads, which passed FASTQC quality control. The sequencing reads were aligned with STAR v2.6.1d against the GRCm38.p6 genome assembly, resulting in an average of 20 × 10 6 aligned pairs per sample and normalized read counts were calculated using Cufflinks v2.2.1 against the same reference genome. Differential gene expression was determined with Cuffdiff and gene ontology analysis performed using Qiagen's Ingenuity Pathway Analysis.
16S library preparation and sequencing analysis. DNA was isolated from stool samples using the Nucleospin Soil kit (Macherey-Nagel). Bacterial 16S rRNA genes were amplified at the V4 region using primer pairs and paired-end amplicon sequencing was performed on the Illumina MiSeq system. The sequencing reads were processed using the DADA2 pipeline in the QIIME2 software package 47 . Beta diversity was calculated using unweighted UniFrac distance 48, 49 . Principle coordinate analysis was performed on the UniFrac distance matrix and visualized with EMPeror 50 .
Statistical analysis. All data were analysed using GraphPad Prism v.7. All graphs show the mean and s.e.m. The number of samples per group is indicated in the figure legends. The log-rank Mantel-Cox test was used for the comparison of survival curves. An unpaired two-tailed Student's t-test was used to evaluate the differences between two groups. Welch's correction was used when variances were significantly different between groups. An ANOVA with Dunnett's or Tukey's multiple comparisons test was used to evaluate experiments involving multiple groups. To analyse bacterial and viral titres, data were log 10 -transformed. Correlations were analysed using Pearson's r. The weight curves were analysed using area under the curve followed by a two-tailed t-test. All P values are shown in the figures.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
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A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
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Data collection
FACSDiva was used to collect Flow cytometry data. RNASeq data was obtained using the Ovation Trio Low Input RNA-seq System V2 (NuGEN) and Illumina's HIseq platform. Bacterial 16S rRNA gene was amplified at the V4 region using primer pairs and paired-end amplicon sequencing was performed on the Illumina MiSeq system.
Data analysis
All analysis except for 16S sequencing and RNASeq was performed using Graphpad Prism v8. ImageJ 1.49v was used for histology analysis. FloJo v 10 was used to analyze all flow cytometry experiments. Bacterial 16S rRNA sequencing reads were processed using the DADA2 pipeline in the QIIME2 software package77. Beta diversity was calculated using unweighted UniFrac distance. Principle Coordinate Analysis (PCoA) was performed on the UniFrac distance matrix and visualized with EMPeror. RNASeq reads were aligned with STAR v2.6.1d against the GRCm38.p6 genome assembly, resulting in an average of 20 million aligned pairs per sample, and normalized read counts were calculated using Cufflinks v2.2.1 against the same reference genome. Differential gene expression was determined with Cuffdiff and gene ontology analysis performed using Qiagen's Ingenuity Pathway Analysis (IPA, Qiagen).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Sample size
The number of animals used in the experiments in this study is estimated based on a power analysis with the following assumptions: standard deviation will be ~20% of the mean, p-value will be under 0.05 when the null hypothesis is false, the effect size (Cohen's d) is between 1.0-2.0. The minimal number of mice required under these conditions ranges between 6-28 for in vivo experiments. Additionally, we have carefully chosen the sample size listed below based on empirical evidence of what is necessary for interpretation of the data and statistical significance.
Data exclusions No data was excluded from the analysis.
Replication
In all experiments, no attempts at replication failed. To confirm the reproducibility of experiments, each independent experiment was analyzed to confirm results before combining multiple replicate experiments.
Randomization Groups were established based off genotype and infection status. All other aspects were randomized.
Blinding
Blinding was used for analysis for all histological analysis by assigning numbers to the samples in place of genotype or infection status. Blinding was not performed for flow cytometry analysis. Blinding was not possible for flow cytometry experiments because all samples were collected and processed on the same day by the same person and strain and infection status were indicated on the mouse cage.
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